Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3053786 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL11081319 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL14608689 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL3046736 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL3051340 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL3041460 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL3051075 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL9713418 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL6018241 | 0.98 | NR5A1 (0.58) | NR5A1NPC1RAB9ATP53HPGD | |
| SCHEMBL9428427 | 0.95 | RARB (0.58) | NR5A1NPC1RAB9ATP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671033-B2 | Amphiphilic dendritic dipeptides and their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-03-02 | — | — | US | disclosed |
| WO-2006085974-A2 | AMPHIPHILIC DENDRITIC DIPEPTIDES & THEIR SELF-ASSEMBLY INTO HELICAL PORES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2006-08-17 | — | — | WO | disclosed |
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2006-04-27 | — | — | US | disclosed |
| WO-2001076626-A2 | LIPOPHILIC AROMATIC ALDEHYDE AND KETONE DERIVATIVES AND THE USE THEREOF AS IMMUNOSTIMULANTS AND ADJUVANTS | GALENICA PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | disclosed |
| EP-0212838-B1 | OPTICALLY ACTIVE LIQUID CRYSTAL COMPOUND HAVING METHYLENEOXY GROUP AND COMPOSITION CONTAINING SAME | Chisso Corporation (JP) | 1990-10-03 | — | — | EP | disclosed |
| US-4729847-A | LIGHT SWITCHING ELEMENT | CHISSO CORPORATION (JP) | 1988-03-08 | — | — | US | disclosed |
| EP-0212838-A1 | Optically active liquid crystal compound having methyleneoxy group and composition containing same | Chisso Corporation (JP) | 1987-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088499-A1 | Amphiphilic dendritic dipeptides & their self-assembly into helical pores | DNPEP, VIP, APLNR | NR5A1 3991/4885NPC1 1117/4885RAB9A 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.